Session: Ovarian cancer prevention

Speaker: Diljeet Singh, MD

This 90-minute concurrent session will focus on risk-management methods for preventing
ovarian cancer in high-risk women. Dr. Singh will present:

• current recommendations for ovarian cancer surveillance in BRCA carriers
• limitations of screening for ovarian cancer in BRCA carriers
• agents that may reduce the risk for ovarian cancer in BRCA carriers
  (OCPs and any new or prior research studies—ie-any available data
  on fenretinide, Vitamin D, or other agents)
• surgical approaches to risk management—salpingo-oophorectomy, tubal ligation
• surgical risks, complications, and recovery time
• considerations regarding including hysterectomy with prophylactic oophorectomy
• importance of consulting with gynecologic-oncologist for preventive surgery and importance of
  following standard-of-care guidelines for surgery (ie- serial sectioning)
  
  

This session is appropriate for:

• survivors and previvors who are considering prophylactic salpingo-oophorectomy
• relatives/loved ones/caretakes of survivors and previvors considering prophylactic
  oophorectomy
• health care providers who treat survivors and previvors
• social workers/mental health care professionals who treat survivors and previvors

Close Window